A former Pfizer employee who bought options in the pharmaceutical giant's stock just prior to its announcement of positive Covid-19 drug data-and then tipped a friend about it who did the same-has been convicted of insider trading.
The interim results from Paxlovid's key clinical trial showed that treatment led to an 89% reduction in hospitalization or death from any cause compared to a placebo.
[
add
]
[
|
|
...
]